Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females

NCT00444704 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Uterine Leiomyomata (Fibroids)

Interventions

DRUG: PRA-027

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer